Drugs / Iscomatrix adjuvant
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02054104 Background | Sep 2014 → Jun 2015 | melanoma, respiratory system cancer, sarcoma, thoracic cancer | National Cancer Institute (NCI) | Terminated | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00199901 Comparator | Sep 2005 → Dec 2008 | melanoma | Ludwig Institute for Cancer Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ISCOMATRIX adjuvant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00199901 ↗ |
| Route | Intramuscular | “four intramuscular injections of ISCOMATRIX® adjuvant alone” NCT00199901 ↗ |